Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes

Oncogene

Volumn 18, Issue 47, 1999, Pages 6469-6476

  Nesbit, Mark ^a   Nesbit, Heike Ke ^a   Bennett, Jean ^b   Andl, Thomas ^a   Hsu, Mei Yu ^a   DeJesus, Emma ^a   McBrian, Michelle ^a   Gupta, Abha R ^b   Eck, Stephen L ^b   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenovirus; bFGF; Melanocytes; Transformation

Indexed keywords

AGAR; BASIC FIBROBLAST GROWTH FACTOR; CYCLIC AMP; FIBROBLAST GROWTH FACTOR 2; INSULIN; MITOGENIC AGENT; PHORBOL ESTER; SOMATOMEDIN C;

ADENOVIRUS 5; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; EXPRESSION VECTOR; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 5;

EID: 0033547426     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203066     Document Type: Article

References (48)

1. Abdel-Malek Z, Swope VB, Pallas J, Krug K and Nordlund JJ. (1992). J. Cell Physiol., 150, 416-425.
2. Ahmed NU, Ueda M, Ito A, Ohashi A, Funasaka Y and Ichihashi M. (1997). Mel. Res., 7, 299-305.
3. al-Alousi S, Barnhill R, Blessing K and Barksdale S. (1996a). J. Cut. Pathol., 23, 506-510.
4. al-Alousi S, Carlson JA, Blessing K, Cook M, Karaoli T and Barnhill RL. (1996b). J. Cut. Pathol., 23, 118-125.
5. Albino AP, Davis BM and Nanus DM. (1991). Cancer Res., 51, 4815-4820.
6. Amalric F, Bouche G, Bonnet H, Brethenou P, Roman AM, Truchet I and Quarto N. (1994). Biochem. Pharmacol., 47, 111-115.
7. Baldin V, Roman AM, Bosc-Bierne I, Amalric F and Bouche G. (1990). EMBO J., 9, 1511-1517.
8. Becker D, Lee PL, Rodeck U and Herlyn M. (1992). Oncogene, 7, 2303-2313.
9. Becker D, Meier CB and Herlyn M. (1989). EMBO J., 8, 3685-3691.
10. Bouche G, Baldin V, Belenguer P, Prats H and Amalric F. (1994). Cell. Mol. Biol. Res.. 40, 547-554.
11. Care A, Silvani A, Meccia E, Mattia G, Stoppacciaro A, Parmiani G, Peschle C and Colombo MP. (1996). Mol. Cell. Biol., 16, 4842-4851.
12. Cohen-Jonathan E, Toulas C, Monteil S, Couderc B, Maret A, Bard JJ, Prats H, Daly-Schveitzer N and Favre G. (1997). Cancer Res., 57, 1364-1370.
13. Coleman AB and Lugo TG. (1998). J. Invest. Dermatol., 110, 793-799.
14. Czubayko F, Liaudet-Coopman ED, Aigner A, Tuveson AT, Berchem GJ and Wellstein A. (1997). Nature Med., 3, 1137-1140.
15. Davol P, Beitz JG and Frackelton Jr AR. (1995). J. Invest. Dermatol., 104, 916-921.
16. De Luca M, Siegrist W, Bondanza S, Mathor M, Cancedda R and Eberle AN. (1993). J. Cell Sci., 105, 1079-1084.
17. deOliveira AR, Castrucci AM and Visconti MA. (1996). Brazilian J. Med. Biol. Res., 29, 1743-1749.
18. Dotto GP, Moellmann G, Ghosh S, Edwards M and Halaban R. (1989). J. Cell Biol., 109, 3115-3128.
19. Florkiewicz RZ, Anchin J and Baird A. (1998). J. Biol. Chem., 273, 544-551.
20. Florkiewicz RZ and Sommer A. (1989). Proc. Natl. Acad. Sci. USA, 86, 3978-3981.
21. Gualandris A, Urbinati C, Rusnati M, Ziche M and Presta M. (1994). J. Cell Physiol., 161, 149-159.
22. Halaban R, Kwon BS, Ghosh S, Delli Bovi P and Baird A. (1988). Oncogene Res., 3, 177-186.
23. Herlyn M, Mancianti ML, Jambrosic J, Bolen JB and Koprowski H. (1988). Exp. Cell Res., 179, 322-331.
24. Herlyn M and Shih IM. (1994). Pig. Cell Res., 7, 81-88.
25. Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P, Clark WH et al. (1994). Cancer Res., 45, 5670-5676.
26. Horikawa T, Norris DA, Zekman T and Morelli JG. (1996). Pig. Cell Res., 9, 58-62.
27. Hsu MY, Shih DT, Meier FE, Van Belle P, Hsu JY, Elder DE, Buck CA and Herlyn M. (1998). Am. J. Path., 153, 1435-1442.
28. Hsu MY, Elder DE and Herlyn M. (1999). Melanoma: The Wistar (WM) melanoma cell lines, In: Masters JRW and Palsson B (eds). Human cell culture. Kluwer Acad. Publications: London, pp. 259-274.
29. Juhasz I, Albelda SM, Elder DE, Murphy GF, Adachi K, Herlyn D, Valyi-Nagy IT and Herlyn M. (1993). Am. J. Path., 143, 528-537.
30. Kozarsky KF and Wilson JM. (1993). Curr. Opin. Genet. Devel., 3, 499-503.
31. Mancianti ML, Gyorfi T, Shih IM, Valyi-Nagy I, Levengood G, Menssen HD, Halpern AC, Elder DE and Herlyn M. (1993). J. Invest. Dermatol., 100, 281S-287S.
32. Nakazawa K, Nakazawa H, Sahuc F, Damour O and Collombel C. (1996). Pig. Cell Res., 9, 28-34.
33. Nelson JE and Kay MA. (1997). J. Virol., 71, 8902-8907.
34. Prats AC, Vagner S, Prats H and Amalric F. (1992). Mol. Cell. Biol., 12, 4796-4805.
35. Quarto N, Talarico D, Florkiewicz R and Rifkin DB. (1991). Cell Reg., 2, 699-708.
36. Quarto N, Talarico D, Sommer A, Florkiewicz R, Basilico C and Rifkin DB. (1989). Onc. Res., 5, 101-110.
37. Reed JA, McNutt NS and Albino AP. (1994). Am. J. Path., 144, 329-336.
38. Rodeck U, Herlyn M, Menssen HD, Furlanetto RW and Koprowsk H. (1987). Int. J. Cancer, 40, 687-690.
39. Salyamoorthy K, DeJesus E, Linnenbach AJ, Kraj B, Kornreich DL, Rendle S, Elder DE and Herlyn M. (1997). Mel. Res., 7, S35-S42.
40. Satyamoorthy K, Nesbit M, Hsu M-Y and Herlyn M. (1996). In: Maio M. (ed.). Immunology of Human Melanoma: Tumor-Host Interaction and Immunotherapy. IOS Press. pp. 71-77.
41. Scott G, Stoler M, Sarkar S and Halaban R. (1991). J. Invest. Dermatol., 96, 318-322.
42. Seno M, Masago A, Nishimura A, Tada H, Kosaka M, Sasada R, Igarashi K, Seno S and Yamada H. (1998). Cytokine, 10, 290-294.
43. Ueda M, Funasaka Y, Ichihashi M and Mishima Y. (1994). Br. J. Dermatol., 130, 320-324.
44. Valyi-Nagy IT, Hirka G, Jensen PJ, Shih IM, Juhasz I and Herlyn M. (1993). Lab. Invest., 69, 152-159.
45. Wang Y and Becker D. (1997). Nature Med., 3, 887-893.
46. Weitzman MD, Wilson JM and Eck SL. (1995). In: Sobol RE and Scanlon KJ (eds). Cancer Therapeutics. Appleton and Lange.
47. Van HC, Juhasz I, Pilewski J, Murphy GF, Hcrlyn M and Albelda SM. (1993). J. Clin. Invest., 91, 986-996.
48. Yayon A, Ma YS, Safran M, Klagsbrun M and Halaban R. (1997). Oncogene, 14, 2999-3009.